HUMAN CORD-BLOOD MONOCYTES UNDERGO TERMINAL OSTEOCLAST DIFFERENTIATION IN-VITRO IN THE PRESENCE OF CULTURE-MEDIUM CONDITIONED BY GIANT-CELLTUMOR OF BONE
S. Roux et al., HUMAN CORD-BLOOD MONOCYTES UNDERGO TERMINAL OSTEOCLAST DIFFERENTIATION IN-VITRO IN THE PRESENCE OF CULTURE-MEDIUM CONDITIONED BY GIANT-CELLTUMOR OF BONE, Journal of cellular physiology, 168(3), 1996, pp. 489-498
Osteoclasts (OCs), which form by fusion of hematopoietic precursor cel
ls, are typically present in large numbers in giant cell tumors of bon
e (GCTBs). These tumors may, therefore, contain cells which secrete fa
ctors that stimulate recruitment and differentiation of OC precursors.
Multinucleated cells resembling OCs also form in cultures of human co
rd blood monocytes (CBMs) stimulated by 1.25 dihydroxyvitamin D-3, but
these cells lack the ability to form bone resorption pits, the defini
ng functional characteristic of mature OCs. CBMs may thus require addi
tional stimulation to form OCs; we therefore investigated whether GCTB
s are a source of such a stimulus. CBMs were stimulated in long term (
21 day) culture by medium conditioned by explants of GCTBs; media coll
ected within 15 days of explant (early-CM) and after 15 days (late-CM)
were employed. We also cocultured CBMs with primary GCTB-derived stro
mal cells as well as immortalized bone marrow stroma-derived cells. CB
Ms stimulated by early-CM formed resorption pits on cortical bone slic
es; however, stimulation by late-CM resulted in virtually no resorptio
n. Both early-CM and late-CM increased CBM proliferation, but not the
proportion of vitronectin receptor positive or multinucleated cells. C
oculture of CBMs with stromal cells of GCTBs or bone marrow did not re
sult in bone resorption, although these stromal cells (most expressing
alkaline phosphatase but progressively losing parathyroid hormone rec
eptor expression) expressed mRNA for cytokines involved in OC differen
tiation, including macrophage-CSF, granulocyte-macrophage-CSF, IL-11,
IL-6, and stem cell factor. Our results indicate that CBMs are capable
of terminal OC differentiation in vitro, a process requiring 1,25 dih
ydroxyvitamin D-3 as well as diffusible factor(s) which can be derived
from GCTB. Stromal cells of GCTB may produce such factors in vivo, bu
t do not support OC differentiation in vitro, possibly through phenoty
pic instability in culture. (C) 1996 Wiley-Liss, Inc.